The genetics and immunology of Peyronie's disease

Citation
Mb. Noss et al., The genetics and immunology of Peyronie's disease, INT J IMPOT, 12, 2000, pp. S127-S132
Citations number
29
Categorie Soggetti
Urology & Nephrology
Journal title
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH
ISSN journal
09559930 → ACNP
Volume
12
Year of publication
2000
Supplement
4
Pages
S127 - S132
Database
ISI
SICI code
0955-9930(200010)12:<S127:TGAIOP>2.0.ZU;2-W
Abstract
Peyronie's disease (PD) is a condition characterized by localized and often progressive fibrosis and scarring of the penis. This condition has an unkn own etiology although several hypotheses have been proposed. These include traumatic, immunologic and genetic causes, We studied the genetics and immu nology of PD using both molecular biologic and molecular genetic techniques . Men (n = 283) with PD were identified by retrospective chart review of one physician's office practice. These men were contacted by telephone and aske d to submit to an interview and blood test for genetic studies, Simultaneou sly, tissue and cells collected in the laboratory were examined by Western and Northern blot analysis for examination of protein and RNA for expressio n of HLA. Of the first 107 men contacted, 24 were available and consented to intervie w and blood testing. The mean age was 60.3 y with an average duration of PD of 4.9 y, One patient had a family history of PD while no patients had Dup uytren's contracture. Twenty patients were considered to have primary disea se while four were secondary. Eleven patients had tissue prepared for North ern blot analysis and nine patients were the subject of Western blot analys is, All tissue, both Peyronie's and control expressed class I MI-IC while n o tissue expressed class II MHC. The expression of mRNA of class I MHC was equal for Peyronie's and control patients while the expression at the prote in level was less in the PD patients. We conclude that PD may have multiple etiologic agents. One cannot exclude a class II MHC association but in our population, HLA DQ is not expressed, Class I MHC may be involved as the expression of class I MHC protein is dif ferent in Peyronie's patients than in controls. Genetic studies are ongoing .